DataVXCellulose Chemistry and TechnologyPaper
journal article·2025-05-16Open access

POLYMERIC NANOPARTICLES ENHANCE THE AQUEOUS SOLUBILITY AND THERAPEUTIC DELIVERY OF DOCETAXEL

Riphah Institute of Pharmaceutical Sciences (RIPS), Riphah International University, Lahore Campus, 54000, Lahore, Pakistan, KANEEZ FIZA ABRESHAM, MUHAMMAD IMRAN KHAN, Riphah Institute of Pharmaceutical Sciences (RIPS), Riphah International University, Lahore Campus, 54000, Lahore, Pakistan, ZULCAIF AHMAD, Riphah Institute of Pharmaceutical Sciences (RIPS), Riphah International University, Lahore Campus, 54000, Lahore, Pakistan, AHSAN ALI, Department of Pharmacy, University of Lahore, Sargodha, Pakistan, MUHAMMAD FURQAN AKHTAR, Riphah Institute of Pharmaceutical Sciences (RIPS), Riphah International University, Lahore Campus, 54000, Lahore, Pakistan

Cellulose Chemistry and Technology· Volume 59· Issue 3-4
Publisher pageOpen full text
Source abstract

Abstract

This study aimed to develop docetaxel (DTX)-loaded polymeric nanoparticles based on chitosan and its combinations with β-cyclodextrin or Poloxamer 188 to improve the dissolution profile of DTX. Three nanoparticle groups were formulated using the ionic gelation method: chitosan-based (F1CS, F2CS, F3CS), chitosan/β-cyclodextrin-based (F1βCS, F2βCS, F3βCS), and chitosan/Poloxamer 188-based (F1PCS, F2PCS, F3PCS). The compatibility between DTX and the formulation components was confirmed using FTIR. Nanoparticle morphology was examined via SEM, and the physical state of the drug was analyzed using DSC and TGA. In vitro drug release was determined using the dialysis bag method. Entrapment efficiency ranged from 55.90 to 82.07% for chitosan-based nanoparticles, 80.80% to 95.13% for β-cyclodextrin-chitosan nanoparticles, and 86.36% to 98.90% for Poloxamer 188-chitosan nanoparticles. SEM analysis showed spherical morphology, and DSC confirmed the amorphous state of DTX. The optimized formulation (F3PCS) demonstrated a sustained release profile. The findings suggest that chitosan-based nanoparticles, combined with β-cyclodextrin and Poloxamer 188, provide a promising approach for enhancing the solubility and bioavailability of DTX.
Source: crossref · Quality: baseline

Research context

PolymersNanomaterials

OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Drug Delivery Systems · Drug Solubulity and Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. "1 M. M. Badran, N. M. Sammour, A. A. Fouda, S. M. Lila, M. S. Abdellatif et al., Biomed. Pharmacother., 106, 1461 (2018), https://doi.org/10.1016/j.biopha.2018.07.03310.1016/j.biopha.2018.07.033 ↗
2. 2 A. Jain, S. K. Hurkat, R. Gulbake, D. K. Jain and S. Jain, Carbohyd. Polym., 137, 65 (2016), https://doi.org/10.1016/j.carbpol.2015.10.01910.1016/j.carbpol.2015.10.019 ↗
3. 3 M. A. Mahmood, T. N. Khan, M. Imran, M. Abbas, S. Batool et al., Int. J. Nanomed., 14, 10035 (2019), https://doi.org/10.2147/IJN.S229572
4. 4 S. Mazzaferro, B. Bonferoni, S. Rossi, T. Sandri, C. Caramella et al., J. Control. Release, 162, 568 (2012), https://doi.org/10.1016/j.jconrel.2012.07.00210.1016/j.jconrel.2012.07.002 ↗
5. 5 S. Saremi, A. Barzegar-Jalali, A. Valizadeh, R. Mohammadpour, N. Adibpour et al., Int. J. Nanomed., 6, 119 (2011), https://doi.org/10.2147/IJN.S14553
6. 6 M. F. Sohail, M. A. Sufian, T. N. Khan, M. Imran and A. K. Kotta, Int. J. Nanomed., 13, 3145 (2018), https://doi.org/10.2147/IJN.S16474810.2147/IJN.S164518 ↗
7. 7 M. Ashrafizadeh, M. R. Zarrabi, M. S. Khorrami, S. M. Abazari, A. Mohammadinejad et al., Int. J. Biol. Macromol., 145, 282 (2020), https://doi.org/10.1016/j.ijbiomac.2019.12.22910.1016/j.ijbiomac.2019.12.229 ↗
8. 8 B. Gidwani and A. Vyas, Biomed. Res. Int., 2015, 902878 (2015), https://doi.org/10.1155/2015/90287810.1155/2015/198268 ↗
9. 9 J. Wu, Q. Shen and L. Fang, Drug Dev. Ind. Pharm., 39, 1010 (2013), https://doi.org/10.3109/03639045.2012.70845810.3109/03639045.2012.694588 ↗
10. 10 P. Rafiei and A. Haddadi, Int. J. Nanomed., 12, 935 (2017), https://doi.org/10.2147/IJN.S12675410.2147/IJN.S121881 ↗
11. 11 W. Fan, Z. Yan, Z. Xu and N. Ni, Colloid. Surface B, 90, 21 (2012), https://doi.org/10.1016/j.colsurfb.2011.10.01310.1016/j.colsurfb.2011.10.013 ↗
12. 12 V. Mikušová and P. J. Mikuš, Int. J. Mol. Sci., 22, 9652 (2021), https://doi.org/10.3390/ijms2217965210.3390/ijms22179652 ↗
13. 13 A. Jain, S. K. Hurkat, R. Gulbake, D. K. Jain and S. Jain, J. Biol. Macromol., 69, 546 (2014), https://doi.org/10.1016/j.ijbiomac.2014.05.06110.1016/j.ijbiomac.2014.05.061 ↗
14. 14 C.-G. Keum, J.-H. Kim, S.-H. Song, S.-H. Yuk and J.-S. Choi, Int. J. Nanomed., 6, 2225 (2011), https://doi.org/10.2147/IJN.S24579
15. 15 A.-L. Cheng, Y.-S. Kang, Z.-Y. Chen, F.-L. Tsao, S.-M. Hsu et al., Lancet Oncol., 10, 25 (2009), https://doi.org/10.1016/S1470-2045(08)70285-710.1016/S1470-2045(08)70285-7 ↗
16. 16 Y. Gu, J. Jin and S. Mei, IEEE Signal Process. Lett., 16, 774 (2009), https://doi.org/10.1109/LSP.2009.202483710.1109/LSP.2009.2024736 ↗
17. 17 S. Modi, S. Stopeck, J. Gordon, G. Sweeney, D. Strickland et al., Clin. Cancer Res., 17, 5132 (2011), https://doi.org/10.1158/1078-0432.CCR-11-059310.1158/1078-0432.CCR-11-0072 ↗
18. 18 A. Rampino, M. T. Manfredi, G. Longhi, P. Ferrari and F. Sonvico, Int. J. Pharm., 455, 219 (2013), https://doi.org/10.1016/j.ijpharm.2013.07.07710.1016/j.ijpharm.2013.07.077 ↗
19. 19 W. Tao, C. Guo, M. Zhang, Y. Gong, Q. Zhang et al., Acta Biomater., 9, 8910 (2013), https://doi.org/10.1016/j.actbio.2013.06.01510.1016/j.actbio.2013.06.015 ↗
20. 20 H. Kulhari, A. G. Tamboli, N. K. Bhise, S. K. Gujar and R. S. Singh, Colloid. Surface B, 117, 166 (2014), https://doi.org/10.1016/j.colsurfb.2014.03.03910.1016/j.colsurfb.2014.03.039 ↗
21. 21 A. Jain, S. K. Hurkat, R. Gulbake, D. K. Jain and S. Jain, Int. J. Biol. Macromol., 69, 546 (2014), https://doi.org/10.1016/j.ijbiomac.2014.05.06110.1016/j.ijbiomac.2014.05.061 ↗
22. 22 A. Grover, S. K. Shandilya, A. K. Kotta, F. J. Molnar and R. N. Patel, AAPS PharmSciTech, 15, 1562 (2014), https://doi.org/10.1208/s12249-014-0176-410.1208/s12249-014-0165-0 ↗
23. 23 A. Lepailleur, F. Flavigny, A. Bonaccorso, O. Sorlin, S. Franchoo et al., Phys. Rev. Lett., 110, 082502 (2013), https://doi.org/10.1103/PhysRevLett.110.08250210.1103/PhysRevLett.110.082502 ↗
24. 24 R. Govindaraju, V. S. Kumar, R. Tata and N. Singh, Pharm. Nanotechnol., 7, 39 (2019), https://doi.org/10.2174/2211738507666190128162548
25. 25 A. Khalid, I. U. Rahman, H. Khan, M. I. Arshad and S. Hussain, Trop. J. Pharm. Res., 17, 2329 (2018), https://doi.org/10.4314/tjpr.v17i12.110.4314/tjpr.v17i12.1 ↗
26. 26 R. C. Dhakar, S. D. Maurya and V. Saluja, J. Drug Deliv. Ther., 2, 1 (2012), https://doi.org/10.22270/jddt.v2i6.36610.22270/jddt.v2i2.33 ↗
27. 27 M. Dawoud, M. A. Abourehab and R. Abdou, J. Drug Deliv. Sci. Technol., 56, 101501 (2020), https://doi.org/10.1016/j.jddst.2020.10150110.1016/j.jddst.2020.101501 ↗
28. 28 Z. Sezgin-Bayindir, A. Bilgili, A. S. Celebioglu, G. Caliskan and N. Yazan, J. Microencapsul., 35, 149 (2018), https://doi.org/10.1080/02652048.2018.145332710.1080/02652048.2018.1447615 ↗
29. 29 M. Giffard, M. Oukhaled, D. Roques, P. Billiald and N. Morel, Cryst. Growth Des., 9, 4199 (2009), https://doi.org/10.1021/cg900316r10.1021/cg900473n ↗
30. 30 M. J. Monteiro and J. de Barbeyrac, Macromolecules, 34, 4416 (2001), https://doi.org/10.1021/ma001770y10.1021/ma0013298 ↗
31. 31 A. A. Mahmoud, M. M. Nasr, N. A. Kassem, O. M. Mohsen and N. A. Mortada, Int. J. Pharm., 413(1-2), 229 (2011). https://doi.org/10.1016/j.ijpharm.2011.04.06710.1016/j.ijpharm.2011.04.067 ↗
32. 32 D. Jain, A. Grover, S. K. Shandilya, R. N. Patel, and A. K. Kotta, Colloid. Surface B, 109, 59 (2013), https://doi.org/10.1016/j.colsurfb.2013.03.05310.1016/j.colsurfb.2013.03.053 ↗
33. 33 S. Bhatia, "Natural Polymer Drug Delivery Systems", Springer, 2016, p. 33, https://doi.org/10.1007/978-3-319-42913-4_210.1007/978-3-319-41129-3_2 ↗
34. 34 M. Danaei, M. Dehghankhold, S. Ataei, F. Hasanzadeh Davarani, R. Javanmardi et al., Pharmaceutics, 10, 57 (2018), https://doi.org/10.3390/pharmaceutics1002005710.3390/pharmaceutics10020057 ↗
35. 35 C. K. Song, I.-S. Yoon and D.-D. Kim, Int. J. Pharm., 507, 102 (2016), https://doi.org/10.1016/j.ijpharm.2016.05.01110.1016/j.ijpharm.2016.05.011 ↗
36. 36 H. Sadaquat and M. Akhtar, J. Incl. Phenom. Macrocycl. Chem., 96, 333 (2020), https://doi.org/10.1007/s10847-020-00985-310.1007/s10847-020-00977-0 ↗
37. 37 M. Naeem, M. M. Shah, S. Khan, S. Munir, F. S. Khan et al., Colloid. Surface B, 123, 271 (2014), https://doi.org/10.1016/j.colsurfb.2014.09.00910.1016/j.colsurfb.2014.09.009 ↗
38. 38 H. Sadaquat, M. A. Ahad, M. A. Shahand M. Akhtar, Int. J. Pharm., 598, 120363 (2021), https://doi.org/10.1016/j.ijpharm.2021.12036310.1016/j.ijpharm.2021.120363 ↗
39. 39 N. Silva, L. Grenho, I. C. Pereira, M. H. Fernandes and P. L. Granja, Nanomaterials, 8, 985 (2018), https://doi.org/10.3390/nano812098510.3390/nano8120985 ↗
40. 40 J. R. Lakkakula and R. W. Maçedo Krause, Nanomedicine, 9, 877 (2014), https://doi.org/10.2217/nnm.13.15510.2217/nnm.13.155 ↗
41. 41 F. Yan, J. Dobrozsi, J. M. Landis, A. P. Torchilin and V. V. Zaitsev, Nanomedicine, 6, 170 (2010), https://doi.org/10.1016/j.nano.2009.07.00710.1016/j.nano.2009.07.007 ↗
42. 42 D. Pandita, S. Kumar, N. Poonia, V. Lather and D. Dhingra, Food Res. Int., 62, 1165 (2014), https://doi.org/10.1016/j.foodres.2014.06.04410.1016/j.foodres.2014.06.044 ↗
43. "